Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2011
09/13/2011CA2425268C Pyridinone derivatives for treatment of atherosclerosis
09/13/2011CA2396937C Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils
09/13/2011CA2250792C Cocoa extract compounds and methods for making and using the same
09/09/2011WO2011109681A1 Fatty acid cox inhibitor derivatives and their uses
09/09/2011WO2011109587A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators
09/09/2011WO2011109355A1 Compounds for immunoproteasome inhibition
09/09/2011WO2011109324A1 Tetrazole compounds which selectively modulate the cb2 receptor
09/09/2011WO2011108955A1 Multi -targeting system comprising a nanocarrier, nucleic acid(s) and non-nucleic acid based drug(s)
09/09/2011WO2011108644A1 Solid pharmaceutical composition and pharmaceutical preparation
09/09/2011WO2011108499A1 Osteoblast differentiation promoter, pharmaceutical composition for promoting ossification, and health food containing auraptene analog as active ingredient
09/09/2011WO2011108000A1 Isolation of a natural lead with potential of p38 mitogen activated protein kinase and c-jun-n terminal kinase inhibiting activity
09/09/2011WO2011107617A1 Liquid ibuprofen/codeine pharmaceutical composition for oral administration, the method for preparation thereof and use thereof
09/09/2011WO2011107590A1 Cnn1 (cyr61) for prevention and therapy of inflammatory disease
09/09/2011WO2011107248A1 NOVEL COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ GAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASE
09/09/2011WO2011107150A1 Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
09/09/2011CA2792003A1 Compositions comprising myristic acid and uses thereof
09/09/2011CA2791805A1 Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
09/09/2011CA2791715A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators
09/09/2011CA2791691A1 Treatment of lupus nephritis using laquinimod
09/09/2011CA2791651A1 Compounds for immunoproteasome inhibition
09/08/2011US20110218248 Organic compounds
09/08/2011US20110218247 Formulations of low dose diclofenac and beta-cyclodextrin
09/08/2011US20110218225 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
09/08/2011US20110218221 Novel histone deacetylase inhibitors, process for preparation and uses thereof
09/08/2011US20110218219 Substituted sulphonamido phenoxybenzamides
09/08/2011US20110218217 Piperidylpropionamide derivatives useful for the treatment of cns disorders including depression and panic disorder
09/08/2011US20110218209 Nutrient delievry drug composition
09/08/2011US20110218207 Isotopically enriched arylsulfonamide ccr3 antagonists
09/08/2011US20110218203 Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
09/08/2011US20110218201 Novel pyrazolone-derivatives and their use as pde-4 inhibitors
09/08/2011US20110218197 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators
09/08/2011US20110218191 Use of meloxicam for the long term-treatment of kidney disorders in cats
09/08/2011US20110218189 PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS
09/08/2011US20110218186 Spirocyclic heterocyclic derivatives and methods of their use
09/08/2011US20110218180 Esters of Capsaicin for Treating Pain
09/08/2011US20110218178 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
09/08/2011US20110218172 Composition for down-regulating pro-inflammatory markers
09/08/2011US20110217398 Extract of aerial parts of oats harvested before ear emergence
09/08/2011US20110217394 Iridoid Based Formulations
09/08/2011US20110217387 Pharmaceutical composition for treatment of fibromyalgia
09/08/2011US20110217376 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same
09/08/2011US20110217339 Mucoactive agents for treating a pulmonary disease
09/08/2011US20110217335 Synthesis of resorcylic acid lactones useful as therapeutic agents
09/08/2011US20110217311 Cycloalkyl containing thienopyrimidines for pharmaceutical compositions
09/08/2011US20110217310 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology
09/08/2011US20110217304 Monoclonal antibodies directed to cd52
09/08/2011US20110217301 Methods for treating or screening for compounds for the treatment of sepsis
09/08/2011US20110217291 Soluble hybrid fct receptors and related methods
09/08/2011US20110217287 Therapeutic composition comprising a botulinum neurotoxin
09/08/2011US20110217272 Treatment of radiation injury using placental stem cells
09/08/2011US20110217271 Treatment of diseases or disorders using placental stem cells
09/08/2011US20110217249 Compositions and Methods for the Treatment of Skin Diseases and Disorders Using Antimicrobial Peptide Sequestering Compounds
09/08/2011US20110217248 Topical Composition
09/08/2011DE102010010288A1 Medicament, useful to prevent or treat e.g. ulcerative colitis, comprises polypeptide sequences of cysteine-rich protein 61 (CCN1) and/or cyclic arginine-glycine-aspartic acid peptide, or nucleic acid encoding polypeptide sequence of CCN1
09/07/2011EP2363150A1 Compositions and methods for enhancing corticosteroid delivery
09/07/2011EP2363138A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring periodontal diseases
09/07/2011EP2363132A1 The use of sophoricoside in preparing medicaments
09/07/2011EP2363121A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions
09/07/2011EP2363120A1 Combinations of dimebolin and memantine
09/07/2011EP2363118A1 Gum resin as a carrier for topical application of pharmacologically active agents
09/07/2011EP2362773A1 Methods for inducing programmed cell death
09/07/2011EP1963288B1 Substituted oxazole derivatives with an analgesic action
09/07/2011EP1853583B1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
09/07/2011CN201959273U 一种新型的活血止痛贴膏 A new Huoxuezhitong Plaster
09/07/2011CN1990475B Substituted benzisoselenazolone compounds and use thereof
09/07/2011CN1914182B Quinazoline derivatives
09/07/2011CN1883618B Effective parts of cirald daphne bark, preparation method and application thereof
09/07/2011CN102177180A Alkylated sem-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
09/07/2011CN102177178A Anti-IL-12/IL-23 antibodies
09/07/2011CN102177161A Pyrimidinyl pyridone inhibitors of JNK
09/07/2011CN102177152A Halofuginone analogs for inhibition of tRNA synthetases and uses thereof
09/07/2011CN102177144A Crystalline forms of (R) -5- [3-chloro-4- ( 2, 3-dihydroxy-propoxy) -benz [Z] ylidene] -2- ( [Z] -propylimino) -3-0-tolyl-thiazolidin-4-one
09/07/2011CN102176911A Novel adenine derivatives
09/07/2011CN102174076A Compounds for proteasome enzyme inhibition
09/07/2011CN102174046A Tetomilast polymorphs
09/07/2011CN102174045A Tetomilast polymorphs
09/07/2011CN102174044A Tetomilast polymorphs
09/07/2011CN102174042A Immunosuppressant compounds and compositions
09/07/2011CN102174024A 2,4-pyrimidinediamine compounds and their uses
09/07/2011CN102172403A Method for treating interleukin-6 related diseases
09/07/2011CN102172398A Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
09/07/2011CN102172397A In vivo targeting of dendritic cells
09/07/2011CN102172370A Method for separating decumbent corydalis tuber total alkaloid with ion exchange resin
09/07/2011CN102172366A Method for separating total alkaloids from motherwort by using ion exchange resin
09/07/2011CN102172365A Method for separating radix sophorae flavescentis total alkaloids by ion exchange resin
09/07/2011CN102172357A Core 2 glcnac-t inhibitors
09/07/2011CN101926826B Method for extracting active ingredients from sea horse
09/07/2011CN101804189B Drug for treating primary dysmenorrhea
09/07/2011CN101785770B Application of methazolamide in preparing medicament for treating ankylosing spondylitis
09/07/2011CN101744804B Application of diacetyl baicalein in preparing antifebrile
09/07/2011CN101703624B Chinese medicinal composition for treating ankylosing spondylitis
09/07/2011CN101700295B Medicinal liquor for relieving dysmenorrhea
09/07/2011CN101664534B External used traditional Chinese medicine for treating scapulohumeral periarthritis
09/07/2011CN101642487B Simultaneous extraction and separation process of baicalin and baicalein in baikal skullcap root
09/07/2011CN101612207B Traditional Chinese medicine for treating headache and preparation method thereof
09/07/2011CN101597337B Conjugate of hydroxyalkyl starch and an active agent
09/07/2011CN101590037B Andrographolidume composition and application thereof
09/07/2011CN101579503B Traditional Chinese medicine for treating rheumatism
09/07/2011CN101569660B External traditional Chinese medicine for relaxing muscles, stimulating blood circulation, diminishing inflammation and relieving pain and preparation method thereof
09/07/2011CN101513522B Chinese medical herbs aerosols for treating anchylosis, painful swelling and preparation method thereof